{"source": ["Nearly two out of three patients in the registry were male n = 408, 65.0%.", "The numbers should be treated with considerable caution, given the large gaps in the prevalence data reported (see figure 11).", "50 patient-records were reviewed, of which 44 88% were males and 6 12% were females.", "For the study, the researchers involved 1,688 participants with an average age of 63 years and followed them for 15 years.", "The population of young people studied entailed 191 cases in 2007 S1 or series 1 and 159 in 2008 S2 or series 2.", "\u00b7 30-34 years: 146 cases (18.30 per cent) of which 78 women (56 per cent).", "Most patients are 1.", "About 465,000 patients are affected.", "Percent less than 18 years old 25.2%", "Figure 1 shows the distribution of the cases by age and gender.", "\u201cData from this new study was also important for designing the clinical trial, including the size and the methods of analysis.\"", "Population aged 14 and under: 26.2%", "7 million patients in 2009.", "In 2011, 90 percent of cases were diagnosed in people 50 and older.", "The nurse/patient ratio was 1:2 or 1:3.", "These studies have indicated that the kaolin-activated TGE reference values do not differ significantly in children between 1 month and 16 years of age and healthy adults.", "About 30% occur in children.", "The median age was 34.8 years.", "An increasing proportion of seropositive was found according to the dates of birth of the individuals born after: from 88.9% in those born between 1990 and 1994, 89.2% in those born between 1995 and 1999 and 92.1% in those born between 2000 and 2003 Figure, A .", "Of 30,579 patients (average age, 14 years), 14,119 used pump therapy and 16,460 used insulin injections.", "majority of patients.", "The researchers examined 400 individuals aged 80-98 over a six-year time period.", "66. In 2010 severe pneumonia and septicaemia accounted for 43% of the deaths of under 1 year old children.", "In an attempt to bring clarity to the topic, UK researchers sifted through the most recent evidence from nine randomized controlled trials \u2013 which are considered medicine's gold standard \u2013 and other systematic reviews of such trials.", "There is an element of safety with this approach because both volume of distribution and clearance expressed as mLmin kg decrease with age throughout childhood and because the elimination half-life is small with a constant context sensitive half-life.", "93 children (62 male; median age 12.4\u2005years) were monitored for a median of 92\u2005days.", "Covariate information e.g. weight, age, pathology, drug interactions, pharmacogenomics can be used to help predict the typical dose in a specific patient.", "Treated over 600 patients", "Seventy-four per cent of new cases occur in our 20-to-49 year-old demographic, with 3 per cent occurring in persons under the age of 15.", "The average age was 53 years old, ranging from 18 to 92. 50 patients 44% were men.", "Participants, on average, were 33 years old, 60 per cdent were men, and the average body mass index and weight were 24 kg/m2 and 65 kg, respectively.", "Patients were divided into 3 groups according to their age.", "Lack of longitudinal growth can be observed at very early stages.", "677. A national survey conducted by the Gender Secretariat in 2006 captured many more cases never before reported to the authorities.", "The majority of cases were males between 30 and 39 years of age.", "Although the most important experience to date with this therapy has been in Italy, S\u00e1nchez Delgado and colleagues in Spain 86 have had a success rate of 84% measured by intention to treat and 90% when measured by protocol.", "These findings are consistent with those observed in the Clinica Rafael Uribe Uribe study in Cali, but with a bleeding rate of 3 to 7 times higher in this study for high risk patients 12.2%, thus the emphasis is on identifying risk groups for not obviate the need for prevention, as even a quarter of them were in danger without their treatment 25.6%.", "Thus, both studies suggested a survival benefit for patients who were treated \"early\".", "In younger, non-ambulatory patients, the incidence of rod breakage was just under than 50%, although a comparison with the older patient group was not statistically significant.", "These findings are consistent with previous studies [16\u201318].", "Approximately 50% of patients die within 18 months of diagnosis.", "The oldest patients", "Although there is an absolute risk of malformations, it is low when compared to other SSIRs.", "Of this number 40.6 % were females.", "Patients are allowed only a clear liquid diet until four hours after the procedure is performed.", "When it comes to children, the amount is lower, but in this work, they are similar to the ones of adults when using the same expected TD.", "Of these, 42.0% presented in patients < 14 years old and 2.4% in patients < 1 year old.", "These patients were observed for a median of 4.9 years.", "59.25% of TMD and OS patients in the sample were female and 40.74% were male.", "Time of evolution is not correlated with clinical status, but is negatively correlated with recovery rate.", "The researchers examined 7,609 Medicare beneficiaries aged 65 to more than 90 years old.", "The Cochrane Review evaluated 30 studies dating from 1990 to 2012 and involving 14,835 participants (Riley & Lamont 2013).", "In addition, the absence of laboratory evidence does not invalidate the findings of poor consensus found between reporting and the systematic application of internationally suggested clinical definitions. This finding reveals an important barrier for the estimation of disease damage and the assessment of interventions, individual and community based, directed at reducing the damage caused by this priority disease.", "Randomized, prospective clinical trials are needed to examine this connection in more detail.", "Among the 2204 children aged 6 - 35 months evaluated, 75.9% had received the MMN n = 1536; the adherence proportion was of 24.4% in those receiving MMN 95%CI 22.3 - 26.6%, which was a significant value p < 0.001.", "Sufferers were more likely to be 45 to 64.", "Final data obtained by The Associated Press show that about 14 percent of the reports filed last year involved male victims.", "There are no conclusive trials in children, but the recommendation is to avoid using it.", "Age Average age: 43.4 years (figure VII)", "As demonstrated by Dr. Koliski in her study, high lactate level was initially a good predictor of death, but only in the initial phase of instability, during the first 24 hours, and not later, when higher stability was achieved.", "A 100 patients were examined, 58 boys 58% and 42 girls 42% ranging from 14 to 48 months of age with a media of 34.6 \u00b1 8.3 months.", "Fifty-two of them, or 82.5 percent, went into remission \u2014 a high rate for such a severe disease.", "We also searched clinical trial registries for ongoing and unpublished studies, and checked reference lists of relevant included studies as well as reviews, meta-analyses and health technology reports to identify additional studies.", "The review of the literature was done on the basis of levels of evidence by order of importance, starting with clinical trials, followed by prospective and retrospective cohorts and, finally, case series.", "The average age is 10 or 11 years,\u201d he said.", "A total of 300 patients took part in the trial at the MAASTRO Clinic (Maastricht, The Netherlands) between May 2009 and April 2012, of whom 76 (25.3%) were aged 75 or older.", "The majority of these patients were between 40 and 70 years old n=2,502, 58.9% with the largest single group in their fifties n=918, 21.6% of cases.", "Definitely, the dimension \"Process of use\" is known by only 36.7 % in the Portuguese population, which points to the fact that there is a percentage of patients who lack the necessary information to ensure they are using the medication correctly. This means that over 60% of the population is at risk of suffering a NRM due to lack of the necessary information to adequately use medication.", "For the period under review, the total percentage of women taking the exam is 49 per cent (1,392 out of 2,831), while the percentage of successful women is 59 per cent (96 out of 163).", "This same study claims that by 65 years of age, 75% of the physicians at low risk for being sued have faced at least one lawsuit, versus 99% of those at high risk.", "New cases among young people, meanwhile, remained steady, averaging about 11.4 additional patients per 100,000 people each year from 2004 to 2015.", "But in a 2014 study, 80% had at least one serious, disabling, or life-threatening health condition by age 45.", "The proportion of men and women is relatively equal between the age of 30 and 49. The population prevalence of women starts from the age of 50 and increases with age.", "(b) Children over six and adolescents;", "And\u202670% of the patients improved."], "hyp": ["\u767b\u8bb0\u5728\u518c\u76843\u540d\u75c5\u4eba\u4e2d\u6709\u8fd12\u540d\u662f\u7537\u6027,n=408,65.0%\u3002", "\u9274\u4e8e\u6240\u62a5\u544a\u7684\u6d41\u884c\u7387\u6570\u636e\u5b58\u5728\u5de8\u5927\u5dee\u8ddd(\u89c1\u56fe11),\u5e94\u5341\u5206\u8c28\u614e\u5730\u5bf9\u5f85\u8fd9\u4e9b\u6570\u5b57\u3002", "\u5bf950\u4e2a\u75c5\u4eba\u8bb0\u5f55\u8fdb\u884c\u4e86\u5ba1\u67e5,\u5176\u4e2d44 88%\u662f\u7537\u6027,6 12%\u662f\u5973\u6027\u3002", "\u5c31\u8fd9\u9879\u7814\u7a76\u800c\u8a00,\u7814\u7a76\u4eba\u5458\u67091 688\u540d\u53c2\u52a0\u8005,\u5e73\u5747\u5e74\u9f8463\u5c81,\u5e76\u8ddf\u8e2a\u4ed6\u4eec15\u5e74\u3002", "2007\u5e74,\u63a5\u53d7\u7814\u7a76\u7684\u9752\u5e74\u4eba\u53e3\u9700\u8981191\u4f8b,2008\u5e74,\u63a5\u53d7\u7814\u7a76\u7684\u9752\u5e74\u4eba\u53e3\u9700\u8981191\u4f8b,S1\u6216\u7cfb\u52171,\u548c159\u4f8b,S2\u6216\u7cfb\u52172\u3002", "30-34\u5c81:146\u4f8b(18.30%),\u5176\u4e2d78\u540d\u5987\u5973(56%)\u3002", "\u591a\u6570\u75c5\u4eba\u4e3a1\u4eba\u3002", "\u7ea6465,000\u540d\u75c5\u4eba\u53d7\u5230\u5f71\u54cd\u3002", "\u4e0d\u6ee118\u5c81\u8005\u767e\u5206\u6bd4 25.2%", "\u56fe1\u663e\u793a\u4e86\u6309\u5e74\u9f84\u548c\u6027\u522b\u5206\u5217\u7684\u6848\u4ef6\u5206\u5e03\u60c5\u51b5\u3002", "\u201c\u8fd9\u9879\u65b0\u7814\u7a76\u7684\u6570\u636e\u5bf9\u4e8e\u8bbe\u8ba1\u4e34\u5e8a\u8bd5\u9a8c\u4e5f\u5f88\u91cd\u8981, \u5305\u62ec\u89c4\u6a21\u548c\u5206\u6790\u65b9\u6cd5\u3002\u201d", "14\u5c81\u53ca14\u5c81\u4ee5\u4e0b\u4eba\u53e3:26.2%", "2009\u5e74\u6709700\u4e07\u75c5\u4eba\u3002", "2011\u5e74,\u572850\u5c81\u53ca50\u5c81\u4ee5\u4e0a\u7684\u4eba\u4e2d,90%\u7684\u75c5\u4f8b\u88ab\u786e\u8bca\u3002", "\u62a4\u58eb/\u75c5\u4eba\u6bd4\u7387\u4e3a1:2\u62161:3\u3002", "\u8fd9\u4e9b\u7814\u7a76\u8868\u660e,\u57281\u4e2a\u6708\u81f316\u5c81\u7684\u513f\u7ae5\u548c\u5065\u5eb7\u6210\u5e74\u4eba\u4e2d,\u8003\u6797\u6fc0\u6d3b\u7684TGE\u53c2\u8003\u503c\u6ca1\u6709\u663e\u8457\u5dee\u5f02\u3002", "\u513f\u7ae5\u7ea6\u536030%\u3002", "\u4e2d\u4f4d\u5e74\u9f84\u4e3a34.8\u5c81\u3002", "\u6839\u636e\u51fa\u751f\u540e\u51fa\u751f\u7684\u4eba\u7684\u51fa\u751f\u65e5\u671f,\u53d1\u73b0\u8840\u6e05\u53cd\u5e94\u5448\u9633\u6027\u7684\u6bd4\u4f8b\u8d8a\u6765\u8d8a\u5927:1990\u5e74\u81f31994\u5e74\u671f\u95f4\u51fa\u751f\u7684\u4eba\u536088.9%,1995\u5e74\u81f31999\u5e74\u671f\u95f4\u51fa\u751f\u7684\u4eba\u536089.2%,2000\u5e74\u81f32003\u5e74\u671f\u95f4\u51fa\u751f\u7684\u4eba\u536092.1%,\u56feA\u3002", "\u572830 579\u540d\u75c5\u4eba(\u5e73\u5747\u5e74\u9f84,14\u5c81)\u300114 119\u540d\u4f7f\u7528\u6cf5\u6cbb\u7597\u548c16 460\u540d\u4f7f\u7528\u80f0\u5c9b\u7d20\u6ce8\u5c04\u4e2d\u3002", "\u591a\u6570\u60a3\u8005\u3002", "\u7814\u7a76\u4eba\u5458\u57286\u5e74\u671f\u95f4\u5bf9400\u540d80-98\u5c81\u7684\u4eba\u8fdb\u884c\u4e86\u4e3a\u671f6\u5e74\u7684\u68c0\u67e5\u3002", "66. 2010\u5e74,\u4e25\u91cd\u80ba\u708e\u548c\u8d25\u8840\u75c7\u53601\u5c81\u4ee5\u4e0b\u513f\u7ae5\u6b7b\u4ea1\u4eba\u6570\u768443%\u3002", "\u4e3a\u4e86\u6f84\u6e05\u8fd9\u4e00\u4e13\u9898,\u82f1\u56fd\u7814\u7a76\u4eba\u5458\u901a\u8fc79\u9879\u968f\u673a\u63a7\u5236\u7684\u8bd5\u9a8c(\u88ab\u8ba4\u4e3a\u662f\u836f\u54c1\u7684\u9ec4\u91d1\u6807\u51c6)\u548c\u5176\u4ed6\u7cfb\u7edf\u5ba1\u67e5\u8fd9\u7c7b\u8bd5\u9a8c,\u7b5b\u9009\u4e86\u6700\u8fd1\u7684\u8bc1\u636e\u3002", "\u91c7\u7528\u8fd9\u79cd\u529e\u6cd5\u6709\u4e00\u4e2a\u5b89\u5168\u56e0\u7d20,\u56e0\u4e3a\u5206\u53d1\u91cf\u548c\u6e05\u9664\u91cf\u5747\u4ee5mLmin\u516c\u65a4\u8868\u793a,\u4e0e\u6574\u4e2a\u7ae5\u5e74\u7684\u5e74\u9f84\u76f8\u6bd4,\u8be5\u7269\u8d28\u5728\u51cf\u5c11,\u800c\u4e14\u6d88\u9664\u7684\u534a\u8870\u671f\u8f83\u5c0f,\u4e14\u5177\u6709\u6301\u7eed\u7684\u73af\u5883\u654f\u611f\u534a\u8870\u671f\u3002", "\u5bf993\u540d\u513f\u7ae5(62\u540d\u7537\u6027;\u4e2d\u4f4d\u5e74\u9f84\u4e3a12.4\u5c81)\u7684\u76d1\u6d4b\u4e2d\u503c\u4e3a92\u5929\u3002", "\u53ef\u4ee5\u5229\u7528\u4f53\u91cd\u3001\u5e74\u9f84\u3001\u75c5\u7406\u5b66\u3001\u836f\u7269\u76f8\u4e92\u4f5c\u7528\u3001\u836f\u7406\u57fa\u56e0\u7ec4\u5b66\u7b49\u5404\u79cd\u4fe1\u606f\u6765\u5e2e\u52a9\u9884\u6d4b\u7279\u5b9a\u75c5\u4eba\u7684\u5178\u578b\u5242\u91cf\u3002", "\u6cbb\u7597600\u591a\u540d\u75c5\u4eba", "74%\u7684\u65b0\u75c5\u4f8b\u53d1\u751f\u5728\u6211\u56fd20-49\u5c81\u4eba\u53e3\u4e2d,3%\u53d1\u751f\u572815\u5c81\u4ee5\u4e0b\u7684\u4eba\u4e2d\u3002", "\u5e73\u5747\u5e74\u9f84\u4e3a53\u5c81,\u4ece18\u5c81\u523092\u5c81\u4e0d\u7b49,50%\u7684\u75c5\u4eba\u662f\u7537\u6027,\u536044%\u3002", "\u53c2\u52a0\u8005\u5e73\u5747\u4e3a33\u5c81,\u6bcf\u53ea\u9f20\u6807\u670960\u540d\u7537\u5b50,\u5e73\u5747\u4f53\u91cd\u6307\u6570\u548c\u4f53\u91cd\u5206\u522b\u4e3a24\u516c\u65a4/\u5e73\u65b9\u7c73\u548c65\u516c\u65a4\u3002", "\u75c5\u4eba\u6309\u5e74\u9f84\u5206\u4e3a3\u7ec4\u3002", "\u7f3a\u4e4f\u7eb5\u5411\u589e\u957f\u5728\u5f88\u65e9\u7684\u9636\u6bb5\u5c31\u53ef\u4ee5\u770b\u5230\u3002", "677. 2006\u5e74,\u4e24\u6027\u5e73\u7b49\u79d8\u4e66\u5904\u8fdb\u884c\u4e86\u4e00\u6b21\u5168\u56fd\u8c03\u67e5,\u8c03\u67e5\u4e86\u6b64\u524d\u4ece\u672a\u5411\u5f53\u5c40\u62a5\u544a\u8fc7\u7684\u66f4\u591a\u6848\u4ef6\u3002", "\u5927\u591a\u6570\u75c5\u4f8b\u662f30\u81f339\u5c81\u7684\u7537\u6027\u3002", "\u5c3d\u7ba1\u8fc4\u4eca\u4e3a\u6b62\u5728\u8fd9\u79cd\u6cbb\u7597\u65b9\u9762\u6700\u91cd\u8981\u7684\u7ecf\u9a8c\u662f\u5728\u610f\u5927\u5229,\u4f46S\u00e1nchez Delgado\u548c\u897f\u73ed\u7259\u540c\u4e8b86\u7684\u6cbb\u7597\u6210\u529f\u7387\u4e3a84%,\u6cbb\u7597\u610f\u5411\u8861\u91cf\u4e3a90%\u3002", "\u8fd9\u4e9b\u8c03\u67e5\u7ed3\u679c\u4e0e\u5361\u5229\u7684Lindica Rafael Uribe Uribe Uribe\u8bca\u6240\u7814\u7a76\u4e2d\u89c2\u5bdf\u5230\u7684\u7ed3\u679c\u4e00\u81f4,\u4f46\u672c\u7814\u7a76\u4e2d\u9ad8\u98ce\u9669\u75c5\u4eba\u7684\u51fa\u8840\u7387\u9ad8\u51fa3\u81f37\u500d,\u4e3a12.2%,\u56e0\u6b64\u91cd\u70b9\u662f\u786e\u5b9a\u98ce\u9669\u7fa4\u4f53,\u4ee5\u514d\u6392\u9664\u9884\u9632\u7684\u5fc5\u8981\u6027,\u56e0\u4e3a\u5373\u4f7f\u5176\u4e2d\u56db\u5206\u4e4b\u4e00\u7684\u4eba\u6ca1\u6709\u63a5\u53d7\u6cbb\u7597,\u4e5f\u5904\u4e8e\u5371\u9669\u4e4b\u4e2d,\u536025.6%\u3002", "\u56e0\u6b64,\u8fd9\u4e24\u9879\u7814\u7a76\u90fd\u4e3a\u201c\u65e9\u671f\u201d\u6cbb\u7597\u7684\u75c5\u4eba\u63d0\u4f9b\u4e86\u751f\u5b58\u798f\u5229\u3002", "\u5728\u8f83\u5e74\u8f7b\u7684\u975e\u95e8\u8bca\u75c5\u4eba\u4e2d,\u68d2\u68d2\u7834\u788e\u7684\u53d1\u751f\u7387\u7565\u4f4e\u4e8e50%,\u5c3d\u7ba1\u4e0e\u8f83\u5e74\u957f\u7684\u75c5\u4eba\u7fa4\u4f53\u76f8\u6bd4,\u5728\u7edf\u8ba1\u4e0a\u5e76\u4e0d\u663e\u8457\u3002", "\u8fd9\u4e9b\u8c03\u67e5\u7ed3\u679c\u4e0e\u4ee5\u5f80\u7684\u7814\u7a76\u4e00\u81f4[16-18]\u3002", "\u5927\u7ea650%\u7684\u75c5\u4eba\u5728\u8bca\u65ad\u540e18\u4e2a\u6708\u5185\u6b7b\u4ea1\u3002", "\u6700\u5e74\u957f\u7684\u75c5\u4eba", "\u867d\u7136\u5b58\u5728\u7578\u5f62\u7684\u7edd\u5bf9\u98ce\u9669,\u4f46\u4e0e\u5176\u4ed6SSIR\u76f8\u6bd4,\u8fd9\u79cd\u98ce\u9669\u8f83\u4f4e\u3002", "\u5176\u4e2d40.6%\u4e3a\u5973\u6027\u3002", "\u75c5\u4eba\u53ea\u6709\u660e\u786e\u7684\u6db2\u4f53\u996e\u98df,\u76f4\u5230\u624b\u672f\u5b8c\u6210\u56db\u4e2a\u5c0f\u65f6\u3002", "\u5728\u513f\u7ae5\u65b9\u9762,\u91d1\u989d\u8f83\u4f4e,\u4f46\u5728\u8fd9\u79cd\u5de5\u4f5c\u4e2d,\u4f7f\u7528\u540c\u6837\u7684\u9884\u671fTD\u65f6,\u4e0e\u6210\u5e74\u4eba\u76f8\u4f3c\u3002", "\u5176\u4e2d42.0%\u4e3a14\u5c81\u4ee5\u4e0b\u75c5\u4eba,2.4%\u4e3a1\u5c81\u4ee5\u4e0b\u75c5\u4eba\u3002", "\u8fd9\u4e9b\u75c5\u4eba\u7684\u4e2d\u4f4d\u6570\u4e3a4.9\u5e74\u3002", "59.25%\u7684TMD\u548cOS\u60a3\u8005\u4e3a\u5973\u6027,40.74%\u4e3a\u7537\u6027\u3002", "\u8fdb\u5316\u65f6\u95f4\u4e0e\u4e34\u5e8a\u72b6\u51b5\u65e0\u5173,\u4f46\u4e0e\u6062\u590d\u7387\u6709\u8d1f\u76f8\u5173\u3002", "\u7814\u7a76\u4eba\u5458\u68c0\u67e5\u4e86\u5e74\u9f84\u572865\u81f390\u5c81\u4ee5\u4e0a\u76847 609\u540d\u300a\u533b\u7597\u4fdd\u5065\u8ba1\u5212\u300b\u53d7\u76ca\u4eba\u3002", "\u300aCochrane\u8bc4\u8bba\u300b\u8bc4\u4f30\u4e861990\u5e74\u81f32012\u5e74\u768430\u9879\u7814\u7a76,\u6d89\u53ca14,835\u4eba(Riley & Lamont,2013\u5e74)\u3002", "\u6b64\u5916,\u7f3a\u4e4f\u5b9e\u9a8c\u5ba4\u8bc1\u636e\u5e76\u4e0d\u80fd\u5426\u5b9a\u5728\u62a5\u544a\u548c\u7cfb\u7edf\u5730\u5e94\u7528\u56fd\u9645\u5efa\u8bae\u7684\u4e34\u5e8a\u5b9a\u4e49\u4e4b\u95f4\u7f3a\u4e4f\u5171\u8bc6\u7684\u7ed3\u8bba,\u8fd9\u4e00\u7ed3\u8bba\u63ed\u793a\u4e86\u5728\u4f30\u8ba1\u75be\u75c5\u635f\u5bb3\u548c\u8bc4\u4f30\u4e2a\u4eba\u548c\u793e\u533a\u5e72\u9884\u65b9\u9762\u7684\u4e00\u4e2a\u91cd\u8981\u969c\u788d,\u8fd9\u4e9b\u5e72\u9884\u65e8\u5728\u51cf\u5c11\u8fd9\u4e00\u4f18\u5148\u75be\u75c5\u9020\u6210\u7684\u635f\u5bb3\u3002", "\u9700\u8981\u968f\u673a\u8fdb\u884c\u53ef\u80fd\u7684\u4e34\u5e8a\u8bd5\u9a8c,\u4ee5\u4fbf\u66f4\u8be6\u7ec6\u5730\u5ba1\u67e5\u8fd9\u4e00\u8054\u7cfb\u3002", "\u5728\u63a5\u53d7\u8bc4\u4f30\u76842 204\u540d6-35\u4e2a\u6708\u513f\u7ae5\u4e2d,75.9%\u7684\u513f\u7ae5\u5f97\u5230MMN n=1536;\u5728\u63a5\u53d7MMN 95% CI 22.3 - 26.6% \u7684\u513f\u7ae5\u4e2d,\u575a\u6301\u7387\u4e3a24.4%,\u8be5\u6bd4\u7387\u503c\u4e3a < 0.001% \" \u3002", "\u53d7\u82e6\u53d7\u96be\u8005\u66f4\u6709\u53ef\u80fd\u662f45\u81f364\u5c81\u3002", "\u7f8e\u8054\u793e\u83b7\u5f97\u7684\u6700\u540e\u6570\u636e\u663e\u793a,\u53bb\u5e74\u63d0\u4ea4\u7684\u62a5\u544a\u4e2d\u7ea6\u670914%\u6d89\u53ca\u7537\u6027\u53d7\u5bb3\u8005\u3002", "\u5728\u513f\u7ae5\u65b9\u9762\u6ca1\u6709\u6700\u540e\u7684\u5ba1\u5224,\u4f46\u5efa\u8bae\u662f\u907f\u514d\u4f7f\u7528\u8fd9\u79cd\u5ba1\u5224\u3002", "\u5e73\u5747\u5e74\u9f84:43.4\u5c81(\u56fe\u4e03)", "\u6b63\u5982\u79d1\u5229\u65af\u57fa\u535a\u58eb\u5728\u5176\u7814\u7a76\u62a5\u544a\u4e2d\u6240\u8868\u660e\u7684\u90a3\u6837,\u9ad8\u4e73\u6db2\u6c34\u5e73\u6700\u521d\u662f\u6b7b\u4ea1\u7684\u826f\u597d\u9884\u6d4b,\u4f46\u53ea\u662f\u5728\u6700\u521d\u7684\u4e0d\u7a33\u5b9a\u9636\u6bb5,\u5728\u6700\u521d\u768424\u5c0f\u65f6\u5185,\u800c\u4e0d\u662f\u540e\u6765\u5b9e\u73b0\u8f83\u9ad8\u7a33\u5b9a\u7684\u65f6\u5019\u3002", "\u5bf9100\u540d\u75c5\u4eba\u8fdb\u884c\u4e86\u68c0\u67e5,58\u540d\u7537\u5b69\u63a5\u53d7\u4e8658%\u7684\u68c0\u67e5,42\u540d\u5973\u5b69\u63a5\u53d7\u4e8642%\u7684\u68c0\u67e5,\u5e74\u9f84\u4ecb\u8d28\u4e3a34.6-8.3\u4e2a\u6708,\u4ecb\u8d28\u4ecb\u8d28\u4ecb\u8d28\u4ecb\u8d28\u4ecb\u8d28\u4ecb\u8d28\u4ecb\u8d28\u4ecb\u8d28\u4ecb\u8d28\u4ecb\u4e8e14-48\u4e2a\u6708\u4e4b\u95f4\u3002", "\u5176\u4e2d52\u4eba(\u536082.5%)\u83b7\u5f97\u7f13\u89e3,\u8fd9\u662f\u8fd9\u79cd\u4e25\u91cd\u75be\u75c5\u7684\u9ad8\u53d1\u7387\u3002", "\u6211\u4eec\u8fd8\u641c\u7d22\u4e86\u4e34\u5e8a\u8bd5\u9a8c\u767b\u8bb0\u518c,\u4ee5\u4fbf\u8fdb\u884c\u4e2d\u548c\u672a\u516c\u5e03\u7684\u7814\u7a76,\u5e76\u6838\u5bf9\u4e86\u5305\u62ec\u7814\u7a76\u548c\u5ba1\u67e5\u3001\u5143\u5206\u6790\u548c\u4fdd\u5065\u6280\u672f\u62a5\u544a\u5728\u5185\u7684\u76f8\u5173\u7814\u7a76\u53c2\u8003\u6e05\u5355,\u4ee5\u786e\u5b9a\u5176\u4ed6\u7814\u7a76\u3002", "\u5ba1\u67e5\u6587\u732e\u7684\u4f9d\u636e\u662f\u6309\u91cd\u8981\u987a\u5e8f\u6392\u5217\u7684\u8bc1\u636e\u6c34\u5e73,\u4ece\u4e34\u5e8a\u8bd5\u9a8c\u5f00\u59cb,\u7136\u540e\u662f\u9884\u671f\u548c\u8ffd\u6eaf\u7ec4\u7fa4,\u6700\u540e\u662f\u6848\u4ef6\u7cfb\u5217\u3002", "\u4ed6\u8bf4,\u5e73\u5747\u5e74\u9f84\u4e3a10\u5c81\u621611\u5c81\u3002\u201d", "2009\u5e745\u6708\u81f32012\u5e744\u6708\u671f\u95f4,\u5171\u6709300\u540d\u75c5\u4eba\u53c2\u52a0\u4e86MAASTRO\u8bca\u6240(\u8377\u5170\u9a6c\u65af\u7279\u91cc\u8d6b\u7279)\u7684\u5ba1\u5224,\u5176\u4e2d76\u4eba(25.3%)\u5e74\u9f84\u572875\u5c81\u621675\u5c81\u4ee5\u4e0a\u3002", "\u8fd9\u4e9b\u75c5\u4eba\u5927\u591a\u572840\u81f370\u5c81\u4e4b\u95f4,\u53732 502\u4eba,\u536058.9%,\u5176\u4e2d50\u5e74\u4ee3\u6700\u5927\u7684\u5355\u4e00\u7fa4\u4f53\u4e3a918\u4eba,\u5360\u75c5\u4f8b\u768421.6%\u3002", "\u786e\u5b9e,\u8461\u8404\u7259\u4eba\u53e3\u4e2d\u53ea\u670936.7%\u7684\u4eba\u77e5\u9053\u201c\u4f7f\u7528\u8fc7\u7a0b\u201d\u7684\u7ef4\u5ea6,\u8fd9\u8bf4\u660e\u6709\u4e00\u5b9a\u6bd4\u4f8b\u7684\u75c5\u4eba\u7f3a\u4e4f\u786e\u4fdd\u6b63\u786e\u4f7f\u7528\u836f\u7269\u7684\u5fc5\u8981\u4fe1\u606f,\u8fd9\u610f\u5473\u774060%\u4ee5\u4e0a\u7684\u4eba\u53e3\u7531\u4e8e\u7f3a\u4e4f\u9002\u5f53\u4f7f\u7528\u836f\u7269\u7684\u5fc5\u8981\u4fe1\u606f\u800c\u9762\u4e34\u60a3NRM\u7684\u98ce\u9669\u3002", "\u5728\u672c\u62a5\u544a\u6240\u8ff0\u671f\u95f4,\u53c2\u52a0\u8003\u8bd5\u7684\u5987\u5973\u603b\u767e\u5206\u6bd4\u4e3a49%(2 831\u4eba\u4e2d\u67091 392\u540d\u5987\u5973),\u6210\u529f\u5987\u5973\u7684\u767e\u5206\u6bd4\u4e3a59%(163\u4eba\u4e2d\u670996\u540d\u5987\u5973)\u3002", "\u540c\u4e00\u7814\u7a76\u8fd8\u58f0\u79f0,\u523065\u5c81\u65f6,75%\u9762\u4e34\u88ab\u8d77\u8bc9\u98ce\u9669\u4f4e\u7684\u533b\u751f\u81f3\u5c11\u9762\u4e34\u4e00\u9879\u8bc9\u8bbc,\u800c\u9ad8\u98ce\u9669\u533b\u751f\u768499%\u9762\u4e34\u8fd9\u4e00\u8bc9\u8bbc\u3002", "\u4e0e\u6b64\u540c\u65f6,\u5e74\u8f7b\u4eba\u7684\u65b0\u75c5\u4f8b\u4fdd\u6301\u7a33\u5b9a,\u4ece2004\u5e74\u81f32015\u5e74,\u5e73\u5747\u6bcf100,000\u4eba\u6bcf\u5e74\u589e\u52a011.4\u4e2a\u75c5\u4eba\u3002", "\u4f46\u57282014\u5e74\u7684\u4e00\u9879\u7814\u7a76\u4e2d,\u523045\u5c81\u65f6,80%\u7684\u4eba\u81f3\u5c11\u6709\u4e00\u79cd\u4e25\u91cd\u3001\u6b8b\u75be\u6216\u5371\u53ca\u751f\u547d\u7684\u5065\u5eb7\u72b6\u51b5\u3002", "30\u81f349\u5c81\u7684\u7537\u5973\u6bd4\u4f8b\u76f8\u5bf9\u76f8\u7b49,\u5987\u5973\u4ece50\u5c81\u5f00\u59cb,\u968f\u7740\u5e74\u9f84\u7684\u589e\u957f\u800c\u589e\u52a0\u3002", "(b) 6\u5c81\u4ee5\u4e0a\u7684\u513f\u7ae5\u548c\u9752\u5c11\u5e74;", "\u8fd8\u6709... 70%\u7684\u75c5\u4eba\u90fd\u597d\u8f6c\u4e86"], "train": [0, 1, 0, 1, 0, 1, 1, 1, 1, 0, 1, 1, 1, 1, 0, 0, 1, 1, 0, 1, 1, 1, 1, 1, 0, 1, 0, 1, 1, 0, 1, 1, 0, 1, 1, 0, 0, 0, 0, 1, 1, 1, 0, 1, 0, 0, 0, 1, 0, 0, 1, 1, 0, 1, 0, 1, 1, 0, 1, 0, 0, 1, 1, 0, 1, 1, 0, 0, 1, 0, 1, 1, 1, 1, 1], "chrf": [null, 0.533, null, 0.482, null, 0.711, 0.196, 0.765, 0.431, null, 0.771, 0.637, 0.722, 0.607, null, null, 0.248, 0.809, null, 0.622, 0.848, 0.566, 0.715, 0.55, null, 0.687, null, 0.318, 0.731, null, 0.475, 0.35, null, 0.668, 0.556, null, null, null, null, 0.678, 0.737, 1.0, null, 0.883, null, null, null, 0.598, null, null, 0.521, 0.692, null, 0.64, null, 0.635, 0.865, null, 0.793, null, null, 0.578, 0.465, null, 0.326, 0.864, null, null, 0.587, null, 0.743, 0.774, 0.353, 0.69, 0.351], "familiarity": [0.38, null, 0.28, null, 0.553, null, null, null, null, 0.399, null, null, null, null, 0.365, 0.416, null, null, 0.253, null, null, null, null, null, 0.631, null, 0.34, null, null, 0.546, null, null, 0.546, null, null, 0.406, 0.506, 0.407, 0.652, null, null, null, 0.63, null, 0.344, 0.517, 0.472, null, 0.11, 0.485, null, null, 0.378, null, 0.54, null, null, 0.324, null, 0.835, 0.536, null, null, 0.392, null, null, 0.41, 0.241, null, 0.424, null, null, null, null, null], "x": [13.295, 8.187, 13.887, 8.518, 10.21, 13.519, 8.22, 8.24, 14.854, 12.4, 7.956, 7.973, 8.176, 8.761, 7.55, 15.376, 10.768, 11.89, 7.933, 17.983, 8.257, 7.874, 8.654, 7.847, 11.365, 11.429, 8.184, 8.277, 10.26, 11.691, 21.726, 8.357, 11.592, 11.917, 12.455, 8.302, 10.478, 8.391, 11.319, 7.354, 8.818, 8.387, 7.618, 13.496, 18.109, 10.748, 8.62, 8.228, 13.355, 8.825, 9.258, 7.859, 7.92, 8.08, 10.959, 10.047, 12.077, 8.612, 12.376, 10.985, 11.121, 8.451, 8.058, 7.894, 11.975, 8.276, 8.286, 9.632, 13.512, 8.187, 9.351, 8.493, 13.625, 11.669, 8.208], "y": [5.539, 14.675, -1.007, 12.948, 6.116, -3.191, 15.874, 15.865, 20.792, 5.989, 16.022, 8.876, 15.904, 16.102, 15.331, 7.717, 11.102, 11.194, 19.699, 6.618, 15.826, 14.3, 18.518, 15.772, 12.248, 11.373, 17.061, 16.083, 7.42, 11.25, 10.131, 15.83, 11.032, -0.857, 6.024, 16.237, 11.271, 16.5, 12.753, 13.812, 15.673, 15.756, 9.439, -3.775, 7.756, 10.766, 15.657, 15.888, -3.122, 15.766, 12.429, 14.304, 15.903, 16.238, 11.832, 12.081, -0.334, 17.357, 11.219, 15.586, 11.035, 16.444, 16.225, 15.567, 11.226, 16.064, 15.132, 19.79, -3.609, 15.277, 13.725, 13.85, -3.415, 11.086, 15.913], "source_id": ["0", null, "0", null, "0", null, null, null, null, "0", null, null, null, null, "0", "0", null, null, "0", null, null, null, null, null, "0", null, "0", null, null, "0", null, null, "0", null, null, "0", "0", "0", "0", null, null, null, "0", null, "0", "0", "0", null, "0", "0", null, null, "0", null, "0", null, null, "0", null, "0", "0", null, null, "0", null, null, "0", "0", null, "0", null, null, null, null, null], "date": [20220315.0, null, 20220207.0, null, 20210619.0, null, null, null, null, 20220324.0, null, null, null, null, 20211117.0, 20210812.0, null, null, 20220301.0, null, null, null, null, null, 20220124.0, null, 20220126.0, null, null, 20210901.0, null, null, 20210601.0, null, null, 20220129.0, 20211029.0, 20211123.0, 20220218.0, null, null, null, 20211015.0, null, 20220221.0, 20211123.0, 20210809.0, null, 20210910.0, 20211126.0, null, null, 20220314.0, null, 20211116.0, null, null, 20210706.0, null, 20211108.0, 20220221.0, null, null, 20210712.0, null, null, 20220327.0, 20210927.0, null, 20211022.0, null, null, null, null, null], "keywords": [["age", 0.021545081918496006], ["patients", 0.02051229655626923], ["born", 0.019323159846549844], ["risk", 0.016636205029329543], ["mmn", 0.016118999281001876], ["correlated", 0.015092113777820458], ["uribe", 0.015092113777820458], ["those", 0.013950871248124634], ["series", 0.013086460805480931], ["months", 0.012897618126890921], ["old", 0.012890917684379957], ["were", 0.012732574828807637], ["children", 0.012569229238416519], ["ranging", 0.01231699985515949], ["lack", 0.011937160720542449], ["medication", 0.01139247809576685], ["years", 0.01125042726025319], ["between", 0.011050349323928704], ["trials", 0.01103366152852168], ["measured", 0.010577477612983988], ["rate", 0.010521396138034343], ["although", 0.010297434781339735], ["male", 0.010076883029320105]]}